Palivizumab-resistant human respiratory syncytial virus infection in infancy
- PMID: 20528472
- DOI: 10.1086/653534
Palivizumab-resistant human respiratory syncytial virus infection in infancy
Abstract
Palivizumab-resistant respiratory syncytial virus was isolated from an infant treated with palivizumab. A stable mutation at codon 276 led to a nearly complete resistance to palivizumab. Additional studies revealed a second mutation at codon 272. Further passage of the virus led to a complete loss of binding of palivizumab.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical